Finance

Lists
NSRX:NYSEAMERICAN
Nasus Pharma Ltd
3,18 $
+0,63%
(+0,020) 1D
14 հոկ, 13:45:07 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NSRX...
Open
3,23 $
High
3,31 $
Low
3,08 $
Mkt. cap
37,25 մլն
Avg. vol.
18,99 հզր
Volume
13,19 հզր
52-wk high
9,50 $
52-wk low
1,98 $
EPS
-1,13 $
Shares outstanding
11,71 մլն
No. of employees
7
Open
3,23 $
High
3,31 $
Low
3,08 $
Mkt. cap
37,25 մլն
Avg. vol.
18,99 հզր
Volume
13,19 հզր
52-wk high
9,50 $
52-wk low
1,98 $
EPS
-1,13 $
Shares outstanding
11,71 մլն
No. of employees
7
News stories
From web sources and news partners
About Nasus Pharma Ltd
CEO-
Employees7
Founded2019
Headquarters-
Sector-
Websitenasuspharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
1,29 մլն
1,29 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
1,73 մլն
1,73 մլն
Operating expense
-
-
3,02 մլն
3,02 մլն
Total operating expenses
-
-
3,02 մլն
3,02 մլն
Operating income
-
-
-3,02 մլն
-3,02 մլն
Other non operating income
-
-
-17,50 հզր
-17,50 հզր
EBT including unusual items
-
-
-2,97 մլն
-2,97 մլն
EBT excluding unusual items
-
-
-2,97 մլն
-2,97 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-2,97 մլն
-2,97 մլն
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
64,00 հզր
64,00 հզր
Interest expense
-
-
-
-
Net interest expenses
-
-
64,00 հզր
64,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps